• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精和药物认知增强 (ACE) 筛查工具:一种简单而简短的问卷,用于筛查物质使用障碍治疗服务中的认知障碍。

The Alcohol and Drug Cognitive Enhancement (ACE) Screening Tool: A simple and brief questionnaire to screen for cognitive impairment in substance use disorder treatment services.

机构信息

Department of Psychology, Macquarie University, Sydney, Australia.

Advanced Neuropsychological Treatment Services, Sydney, Australia.

出版信息

Appl Neuropsychol Adult. 2022 Nov-Dec;29(6):1450-1457. doi: 10.1080/23279095.2021.1888727. Epub 2021 Mar 1.

DOI:10.1080/23279095.2021.1888727
PMID:33646853
Abstract

The objective of this study was to determine the test-retest reliability; construct and criterion validity; and test operating characteristics of a newly developed cognitive impairment risk factor screening instrument, the Alcohol and Drug Cognitive Enhancement (ACE) Screening Tool. Participants in the validation study were 129 adults with substance use disorder (SUD) enrolled in residential SUD treatment services and 209 normal controls. Test and retest data were available for 36 participants with SUD and 40 normal control individuals on the ACE Screening Tool. Test-retest reliability was excellent (ICC = 0.97). The ACE Screening Tool was significantly correlated with the Montreal Cognitive Assessment (MoCA), Behavior Rating Inventory of Executive Functioning-Adult Version (BRIEF-A), Test of Premorbid Functioning (TOPF) and Five Point Test, establishing construct validity. Criterion validity was established using a ternary severity variable constructed using results obtained on the MoCA and BRIEF-A. Test operating characteristics analysis showed 93% sensitivity, 46% specificity, 33% positive predictive power, and 96% negative predictive power using a cut-score of >3. Those high levels of sensitivity and negative predictive power indicated that the tool would likely detect cognitive impairment when present and should therefore be considered suitable as an initial screening tool for cognitive impairment in individuals attending SUD services.

摘要

本研究旨在确定新开发的认知障碍风险因素筛查工具——酒精和药物认知增强(ACE)筛查工具的重测信度、结构效度和测试工作特征。验证研究的参与者包括 129 名患有物质使用障碍(SUD)的成年人和 209 名正常对照者,他们被纳入住院 SUD 治疗服务。36 名 SUD 患者和 40 名正常对照者有 ACE 筛查工具的测试和重测数据。重测信度非常高(ICC=0.97)。ACE 筛查工具与蒙特利尔认知评估(MoCA)、行为评定量表认知执行功能成人版(BRIEF-A)、预患病能力测验(TOPF)和五分测验显著相关,确立了结构效度。使用 MoCA 和 BRIEF-A 结果构建的三分严重程度变量建立了标准效度。使用>3 的截断分数进行测试工作特征分析显示,敏感性为 93%,特异性为 46%,阳性预测值为 33%,阴性预测值为 96%。这些高敏感性和阴性预测值表明,该工具在存在认知障碍时可能会检测到认知障碍,因此应被视为 SUD 服务中认知障碍的初始筛查工具。

相似文献

1
The Alcohol and Drug Cognitive Enhancement (ACE) Screening Tool: A simple and brief questionnaire to screen for cognitive impairment in substance use disorder treatment services.酒精和药物认知增强 (ACE) 筛查工具:一种简单而简短的问卷,用于筛查物质使用障碍治疗服务中的认知障碍。
Appl Neuropsychol Adult. 2022 Nov-Dec;29(6):1450-1457. doi: 10.1080/23279095.2021.1888727. Epub 2021 Mar 1.
2
Brief executive-function assessment tool: A new cognitive impairment screening tool for alcohol and other drug services.简易执行功能评估工具:酒精和其他药物服务中的新型认知障碍筛查工具。
Appl Neuropsychol Adult. 2022 Nov-Dec;29(6):1511-1521. doi: 10.1080/23279095.2021.1895791. Epub 2021 Apr 8.
3
Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.验证蒙特利尔认知评估量表(MoCA-TR)土耳其语版本在帕金森病患者中的应用。
Clin Neuropsychol. 2014;28(2):333-43. doi: 10.1080/13854046.2014.881554. Epub 2014 Feb 17.
4
Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.验证蒙特利尔认知评估的西班牙语版本作为多发性硬化症认知障碍的筛查测试。
Neurologia (Engl Ed). 2022 Nov-Dec;37(9):726-734. doi: 10.1016/j.nrleng.2019.11.007. Epub 2021 Nov 23.
5
Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.物质使用者的认知筛查:简易精神状态检查表、修订版剑桥认知检查表及蒙特利尔认知评估量表的诊断准确性
J Clin Exp Neuropsychol. 2018 Mar;40(2):107-122. doi: 10.1080/13803395.2017.1316970. Epub 2017 Apr 24.
6
Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.使用 MoCA 或 BRIEF-A 测量患有多种物质使用障碍的年轻成年人的认知障碍 - 精神症状的意义。
J Subst Abuse Treat. 2019 Feb;97:21-27. doi: 10.1016/j.jsat.2018.11.010. Epub 2018 Nov 22.
7
Validity of the Cantonese Chinese Montreal Cognitive Assessment in Southern Chinese.粤语版蒙特利尔认知评估量表在中国南方人群中的效度
Geriatr Gerontol Int. 2015 Jan;15(1):96-103. doi: 10.1111/ggi.12237. Epub 2014 Jan 24.
8
Performance on Cognitive Screening Tests and Long-Term Substance Use Outcomes in Patients with Polysubstance Use Disorder.多药使用障碍患者认知筛查测试表现与长期物质使用结局的关系。
Eur Addict Res. 2023;29(2):150-159. doi: 10.1159/000528921. Epub 2023 Apr 20.
9
Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.蒙特利尔认知评估筛查工具在患有和未患有先天性心脏病的青少年及青年中的有效性。
Nurs Res. 2017 May/Jun;66(3):222-230. doi: 10.1097/NNR.0000000000000192.
10
Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.验证中文版 Addenbrooke's 认知测验 III 用于检测轻度认知障碍。
Aging Ment Health. 2022 Feb;26(2):384-391. doi: 10.1080/13607863.2021.1881757. Epub 2021 Feb 3.

引用本文的文献

1
Cognitive impairment in alcohol use disorder and clinical practice guidelines for management of long-stay alcohol use disorder patients.酒精使用障碍中的认知障碍及长期酒精使用障碍患者管理的临床实践指南。
Indian J Psychiatry. 2025 Jan;67(1):144-157. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_692_24. Epub 2025 Jan 13.
2
New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need.新南威尔士州酒精及其他药物服务提供者对客户变量在确定治疗需求方面相对重要性的看法。
Drug Alcohol Rev. 2025 Jan;44(1):195-225. doi: 10.1111/dar.13952. Epub 2024 Oct 21.